Search Results
Showing Results for young people
Dr. Ikechukwu B. Moses, winner of the ESCMID Global 2025 Emerging Young Investigator Award, explores antimicrobial resistance through a One Health lens. His work spans zoonotic pathogen transmission, bacteriophage therapy, and AI-driven genomic research, aiming to reduce antibiotic reliance and translate lab-based innovations into scalable, real-world clinical and veterinary solutions.
Dr Simon Feys discusses his journey into intensive care medicine, driven by the complexity and impact of treating critically ill patients. He highlights the central role of infections in ICU, the importance of broad medical knowledge, and how clinical experience and research together shape his approach to patient care and innovation.
Q&A with ESCMID Young Investigator 2025 Dr Xin Hui Chan: touchINFECTIOUS DISEASES Future Leader 2025
Dr Xin Hui Chan’s research focuses on developing equitable therapies for high-threat infectious diseases. She combines clinical trials, evidence synthesis, and modelling to address neglected infections and improve global health outcomes.
touchINFECTIOUS DISEASES were thrilled to speak with Professor Barbara Van Der Pol (Professor of Medicine and Public Health, University of Alabama at Birmingham, AL) about her perspectives on recent advances in sexually transmitted infection (STI) diagnostic tools, management and breaking ...
Topline results from phase III PURPOSE 1 trial (NCT04994509) demonstrate the twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, achieved 100% efficacy in preventing HIV infections in cisgender women. Â
The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1Â Currently, there are an estimated 30 million people on antiretroviral treatment for HIV ...
Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1Â Worldwide, RSV is the second leading cause of death (second to malaria) in children during ...
Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...
HIV is a significant global health issue for which there is no cure. However, the availability of antiretroviral therapy (ART) has made it possible to effectively treat and prevent HIV infection, leading to a considerable decrease in associated deaths and ...
The Centers for Disease Control and Prevention has recognized that people with HIV are at a greater risk for severe disease and death than those without HIV, when hospitalized with coronavirus disease 2019 (COVID-19).1–3 It is also known that individuals with ...
While the global commitment to treating HIV has saved countless lives, efforts to prevent new HIV infections have not been so fruitful. The annual number of new HIV infections among adults worldwide has barely changed over the past 5 years, with ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
